You are here
Photocleavable ICAT Reagents for Quantitative Proteomics
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43GM070325-01
Agency Tracking Number: GM070325
Amount:
$99,992.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
AMBERGEN, INC.
1106 COMMONWEALTH AVE
BOSTON, MA
02215
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: JERZY Olejnik
Phone: (617) 975-0685
Email: JERZY@AMBERGEN.COM
Phone: (617) 975-0685
Email: JERZY@AMBERGEN.COM
Business Contact
Name: NORMAN PRIEBATSCH
Phone: (617) 975-0688
Email: NEP@AMBERGEN.COM
Phone: (617) 975-0688
Email: NEP@AMBERGEN.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Proteomics is set to have a profound impact on disease diagnosis, treatment and monitoring. Protein expression profiling is one of the important parameters that can be monitored in the course of neoplastic disease.
* Information listed above is at the time of submission. *